BIOPTEQ financials
A multi-period view of the public annual-account figures reported for BIOPTEQ, with comparable measures and links to available source documents.
Company overviewRegistry number
0877753196
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for BIOPTEQ
2025 versus 2024
- Operating line
- €120,321
- EBITDA
- €100,929
- Total assets
- €972,092
- Equity
- €808,624
+25%
+30.7%
+10.6%
-0.9%
EBITDA margin +83.9% · Equity ratio +83.2%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.